Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Babylon Health needs to restore consumer trust to benefit from expected rise in popularity of virtual appointments, says GlobalData

Following the news that virtual health insurer, Babylon Health, has suffered a data breach; Ben Carey-Evans, Insurance Analyst at GlobalData, offers his view: “Babylon Health will need to reassure potential customers that their data is safe in order to capitalize on what is looking to be a promising time for virtual appointments. GlobalData’s 2019 UK […]
Read more

Expedia shutting multifamily business illustrates slower demand recovery in urban areas, says GlobalData

Following a recent announcement that Expedia Group has permanently closed its multifamily solutions business; Ralph Hollister, Analyst, Travel & Tourism at GlobalData, a leading data and analytics company, offers his view on the situation: “The current streamlining of operations within Expedia, combined with a lack of urban demand due to COVID-19, means the company will […]
Read more

Exelon maintains 2020 earning guidance and will offset impact of uncertain market conditions amid COVID-19, says GlobalData

Despite the reduction in demand due to the pandemic, Exelon has managed to maintain its 2020 earning guidance because the adjusted (non-GAAP) operating earnings remained consistent at $0.87 per share in Q1 2020. However, it is expected that Exelon’s utilities and Generation companies will undergo a reduction in operating revenues due to lower electric load […]
Read more

NATO-Turkey ties may find new grounds as cooperation deepens, says GlobalData

Following the news regarding Turkey’s participation in Baltic Operations (BALTOPS 2020) exercise; Sourabh Banik, Aerospace & Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “Turkey’s participation in the BALTOPS 2020 is an interesting development against the backdrop of a thriving connection between Ankara and Moscow, as the BALTOPS exercise intends […]
Read more

Effects of the COVID-19 pandemic to bring temporary service irregularities resulting in a contraction in nuclear power generation, says GlobalData

As nuclear plants plan to continue operation in the pandemic they face a stiff challenge from a reduced workforce. The general safety embedded measures implemented in plants across the world are modified work schedules, adherence to social distancing guidelines. This has led to the drop in workforce availability, overburdening workers on-site, as their work schedules […]
Read more

Remdesivir faces challenges from vaccines, says GlobalData

While Gilead Sciences’ remdesivir has been declared the new standard of care for COVID-19 despite some mixed trial results, it will continue to face challenges from vaccines in the pipeline, says GlobalData, a leading data and analytics company. Once a vaccine is developed, the demand for remdesivir to treat COVID-19 patients will decline. Johanna Swanson, […]
Read more

Enterprise cloud spending will surpass $590bn by 2024, says GlobalData

Enterprise spending on cloud services and infrastructure will grow to $591.4bn by 2024, up from $398.0bn in 2020 at a compound annual growth rate (CAGR) of 8%, says GlobalData, a leading data and analytics company. According to the company’s latest report, ‘Thematic Research: Cloud Computing’, cloud computing’s importance has grown significantly in recent years. The […]
Read more

Amid the COVID-19, the partnership with Eneris, to relieve Leclanche off capital burden while guaranteeing production capacity, says GlobalData

The comprehensive Strategic partnership agreements signed between Leclanche and Eneris Group is likely to create a market-leading Joint Venture (JV). Amid the COVID-19, Leclanche had planned for a strategic reorganization. The partnership with Eneris Group will enable the Company to secure the funding and resources that are likely to help the Company achieve its goal […]
Read more

Ferring’s recent Milprosa approval set to partially address unmet need in the female infertility space, says GlobalData

Ferring Pharmaceuticals recently gained FDA approval for Milprosa, a once-weekly progesterone vaginal ring for the luteal phase support in women undergoing Assisted Reproductive Technology (ART) treatment cycles. According to GlobalData, US sales of the various progesterone options used for luteal phase support during ART cycles were estimated at $78M in 2019. By 2028 sales are […]
Read more

Eligibility questions remain about publicly traded bio/pharma companies that received Paycheck Protection Program loans, says GlobalData

At least 49 publicly traded bio/pharmaceutical companies took Paycheck Protection Program (PPP) loans from the US Government’s $659bn program despite official guidance that the money was not intended for large public companies, says GlobalData, a leading data and analytics company. Peter Shapiro, PhD, PharmSource and Senior Director, Drugs and Business Fundamentals Databases at GlobalData, comments: […]
Read more

Technology vendors target edge computing opportunities with innovative solutions, strategies and business models, says GlobalData

According to GlobalData’s new Competitive Landscape Assessment for Edge Computing Infrastructure, businesses, government and other organizations will invest in edge computing in order to harness several benefits. These include its ability to support a host of new digital applications that rely on high levels of performance such as video analytics, autonomous driverless vehicles, and immersive […]
Read more
1 … 55 56 57 58 59 … 77